| Peripheral blood CD3+CD26+ | Peripheral blood CD4+CD26+ | Synovial fluid CD3+CD26+ | Serum/plasma DPPIV activity (μmol/min/l) | Synovial DPPIV activity (μmol/min/l) | Notes | Reference |
---|---|---|---|---|---|---|---|
Controls | 12.9 ± 4.7 |  |  |  |  | Ta1 antibody; all active with therapy | [47] |
RA (active) | 40.2 ± 10.6 |  |  |  |  | Ta1 antibody; all active with therapy | [47] |
Controls | 58.2 ± 10.6 |  |  |  |  | 1F7 antibody; all active with therapy | [47] |
RA (active) | 72.0 ± 8.8 |  |  |  |  | 1F7 antibody; all active with therapy | [47] |
Controls |  | 12.3 ± 4.2 |  |  |  | Ta1 antibody | [49] |
OA |  | 8.1 ± 2.0 |  |  |  | Ta1 antibody | [49] |
RA (inactive) |  | 41.6 ± 23.1 |  |  |  | Ta1 antibody | [49] |
RA (active) |  | 62.2 ± 10.1 |  |  |  | Ta1 antibody | [49] |
Controls | 58.8 ± 9.0 |  |  |  |  | 1F7 antibody | [123] |
OA |  |  | 49.0 ± 11.0 |  |  | 1F7 antibody | [123] |
RA (inactive) | 60.6 ± 4.0 |  |  |  |  | 1F7 antibody | [123] |
RA (active) | 75.9 ± 10.0 |  | 36.3 ± 10.0 |  |  | 1F7 antibody | [123] |
OA |  |  |  | 36.7 ± 6.5 (CD26: 614 ± 157 ng/ml) | 14.6 ± 4.4 (CD26: 247 ± 25 ng/ml) |  | [55] |
RA | Â | Â | Â | Â | Â | Â | [55] |
All |  |  |  | 26.7 ± 9.9 (CD26: 473 ± 176 ng/ml) | 16.1 ± 5.6 (CD26: 259 ± 80 ng/ml) |  | [55] |
Non-inflammatory |  |  |  | 31.8 ± 12.7 (CD26: 558 ± 195 ng/ml) |  | (n = 24; CRP < 20 mg/l) | [55] |
Inflammatory |  |  |  | 22.4 ± 4.7 (CD26: 404 ± 139 ng/ml) |  | (n = 17; CRP > 20 mg/l) | [55] |
Controls |  |  |  | 41.3 ± 4.7 |  |  | [32] |
RA (active) |  |  |  | 34.5 ± 3.2 |  |  | [32] |
SLE |  |  |  | 29.9 ± 6.5 |  |  | [32] |
OA |  |  |  |  | 702.6 ± 41.2 mU/mg | Synovial fluid | [60] |
RA (active) |  |  |  |  | 549.6 ± 28.3 mU/mg | Synovial fluid | [60] |
Controls |  |  |  | 634 μmol/min/mol |  |  | [36] |
Sjogren's syndrome |  |  |  | 969 μmol/min/mol |  |  | [36] |
SLE |  |  |  | 650 μmol/min/mol |  |  | [36] |
RA (active) |  |  |  | 224 μmol/min/mol |  |  | [36] |
OA |  |  |  |  | 1.0 ± 1.4 nmol/min/mg | Synovial membranes | [54] |
RA (active) | Â | Â | Â | Â | Â | Â | Â |
All grades |  |  |  |  | 1.1 ± 1.1 nmol/min/mg | Synovial membranes | [54] |
Grade 1 (0–10 ml fluid) |  |  |  |  | 1.8 ± 1.4 nmol/min/mg | Synovial membranes | [54] |
Grade 2 (10–20 ml fluid) |  |  |  |  | 0.9 ± 0.6 nmol/min/mg | Synovial membranes | [54] |
Grade 3 (> 20 ml fluid) |  |  |  |  | 0.6 ± 0.5 nmol/min/mg | Synovial membranes | [54] |